184 related articles for article (PubMed ID: 27761077)
21. In vitro activity of linezolid & quinupristin/dalfopristin against Gram-positive cocci.
Tünger A; Aydemir S; Uluer S; Cilli F
Indian J Med Res; 2004 Dec; 120(6):546-52. PubMed ID: 15654141
[TBL] [Abstract][Full Text] [Related]
22. [In vitro activity of ceftaroline against Spanish isolates of Staphylococcus aureus: a multicenter study].
Tenorio-Abreu A; Gil Tomás J; Bratos Pérez MÁ; de la Iglesia Salgado A; Borrás Máñez M; Ortiz de Lejarazu Leonardo R; Ávila Alonso A; Colomina Rodríguez J; Pérez Cáceres JA; Saavedra Martín JM; Márquez Sanabria A; Domínguez Castaño A; de la Iglesia Salgado M
Enferm Infecc Microbiol Clin; 2015 Feb; 33(2):101-4. PubMed ID: 25091384
[TBL] [Abstract][Full Text] [Related]
23. Susceptibility trends including emergence of linezolid resistance among coagulase-negative staphylococci and meticillin-resistant Staphylococcus aureus from invasive infections.
Decousser JW; Desroches M; Bourgeois-Nicolaos N; Potier J; Jehl F; Lina G; Cattoir V; Vandenesh F; Doucet-Populaire F;
Int J Antimicrob Agents; 2015 Dec; 46(6):622-30. PubMed ID: 26453147
[TBL] [Abstract][Full Text] [Related]
24. [Study of marine actinomycetes isolated from the central coast of Peru and their antibacterial activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis].
León J; Aponte JJ; Rojas R; Cuadra D; Ayala N; Tomás G; Guerrero M
Rev Peru Med Exp Salud Publica; 2011 Jun; 28(2):237-46. PubMed ID: 21845303
[TBL] [Abstract][Full Text] [Related]
25. The antibacterial activity of topical retinoids: the case of retinaldehyde.
Pechère M; Germanier L; Siegenthaler G; Pechère JC; Saurat JH
Dermatology; 2002; 205(2):153-8. PubMed ID: 12218231
[TBL] [Abstract][Full Text] [Related]
26. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
Sader HS; Watters AA; Fritsche TR; Jones RN
BMC Infect Dis; 2007 Apr; 7():29. PubMed ID: 17442104
[TBL] [Abstract][Full Text] [Related]
27. Synergistic effect of artocarpin on antibacterial activity of some antibiotics against methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli.
Septama AW; Panichayupakaranant P
Pharm Biol; 2016; 54(4):686-91. PubMed ID: 26427318
[TBL] [Abstract][Full Text] [Related]
28. Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006).
Fritsche TR; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2008 May; 61(1):86-95. PubMed ID: 18385000
[TBL] [Abstract][Full Text] [Related]
29. In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.
Lascols C; Legrand P; Mérens A; Leclercq R; Muller-Serieys C; Drugeon HB; Kitzis MD; Reverdy ME; Roussel-Delvallez M; Moubareck C; Brémont S; Miara A; Gjoklaj M; Soussy CJ
Int J Antimicrob Agents; 2011 Mar; 37(3):235-9. PubMed ID: 21295447
[TBL] [Abstract][Full Text] [Related]
30. In vitro activity of fusidic acid and mupirocin against coagulase-positive staphylococci from pets.
Loeffler A; Baines SJ; Toleman MS; Felmingham D; Milsom SK; Edwards EA; Lloyd DH
J Antimicrob Chemother; 2008 Dec; 62(6):1301-4. PubMed ID: 18819974
[TBL] [Abstract][Full Text] [Related]
31. Update of dalbavancin spectrum and potency in the USA: report from the SENTRY Antimicrobial Surveillance Program (2011).
Jones RN; Sader HS; Flamm RK
Diagn Microbiol Infect Dis; 2013 Mar; 75(3):304-7. PubMed ID: 23357293
[TBL] [Abstract][Full Text] [Related]
32. Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and β-haemolytic streptococci collected from western European countries in 2011.
Morrissey I; Seifert H; Canton R; Nordmann P; Stefani S; Macgowan A; Janes R; Knight D;
J Antimicrob Chemother; 2013 Jan; 68(1):164-7. PubMed ID: 22941898
[TBL] [Abstract][Full Text] [Related]
33. In vitro activities of quinupristin/dalfopristin and eight other antimicrobial agents against 360 clinical isolates from Korea.
Hwang SH; Kim MN; Pai CH; Huh DH; Shin WS
Yonsei Med J; 2000 Oct; 41(5):563-9. PubMed ID: 11079615
[TBL] [Abstract][Full Text] [Related]
34. In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci.
Jones RN; Deshpande LM; Mutnick AH; Biedenbach DJ
J Antimicrob Chemother; 2002 Dec; 50(6):915-32. PubMed ID: 12461013
[TBL] [Abstract][Full Text] [Related]
35. Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models.
Smith JR; Barber KE; Hallesy J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2015 Sep; 59(9):5529-34. PubMed ID: 26124162
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: activity against staphylococci and enterococci.
Putnam SD; Sader HS; Farrell DJ; Biedenbach DJ; Castanheira M
Int J Antimicrob Agents; 2011 Jan; 37(1):39-45. PubMed ID: 21075602
[TBL] [Abstract][Full Text] [Related]
37. Antibacterial and Antibiofilm Potential of Bacterial Cellulose Hydrogel Containing Vancomycin against Multidrug-Resistant
Correia AAV; de Almeida Campos LA; de Queiroz Macêdo HLR; de Lacerda Coriolano D; Agreles MAA; Xavier DE; de Siqueira Ferraz-Carvalho R; de Andrade Aguiar JL; Cavalcanti IMF
Biology (Basel); 2024 May; 13(5):. PubMed ID: 38785836
[TBL] [Abstract][Full Text] [Related]
38. In vitro activities of ME1036 (CP5609), a novel parenteral carbapenem, against methicillin-resistant staphylococci.
Kurazono M; Ida T; Yamada K; Hirai Y; Maruyama T; Shitara E; Yonezawa M
Antimicrob Agents Chemother; 2004 Aug; 48(8):2831-7. PubMed ID: 15273088
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial activity of daptomycin tested against Gram-positive pathogens collected in Europe, Latin America, and selected countries in the Asia-Pacific Region (2011).
Sader HS; Flamm RK; Jones RN
Diagn Microbiol Infect Dis; 2013 Apr; 75(4):417-22. PubMed ID: 23514757
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial resistance trends among 5608 clinical Gram-positive isolates in China: results from the Gram-Positive Cocci Resistance Surveillance program (2005-2010).
Zhao C; Sun H; Wang H; Liu Y; Hu B; Yu Y; Sun Z; Chu Y; Cao B; Liao K; Lei J; Hu Z; Zhang L; Zhang X; Xu Y; Wang Z; Chen M
Diagn Microbiol Infect Dis; 2012 Jun; 73(2):174-81. PubMed ID: 22521693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
